On Wednesday, October 19, 2022, the Forum for Collaborative Research convened its 7th TAVI Forum meeting at the National Press Club in Washington, DC. The goal of the TAVI Forum is to advance the regulatory sciences for the treatment of TAVI and its associated morbidities by providing an independent and neutral venue for ongoing multi-stakeholder dialogue. The meeting entailed updates from the Adenovirus Working Group, the BK Virus Working Group, as well as updates regarding the advancement of CMV definitions.
Materials
Presentations
Session I: Adenovirus Working Group Discussion
Virology Challenges in ADV Clinical Trials & Challenges in Clinical Trial Designs
Per Ljungman, Karolinska Institutet
Session II: Launch of CMV Definitions Update
Summary of 2016 CMV Paper & Discussion
Per Ljungman, Karolinska Institutet
Immune Monitoring for CMV
Frederique Sauve, McGill University
Session III: BK Working Group Update Summary of 2022 BKPyV Nephropathy Definitions Paper
Hannah Imlay, University of Utah
BK Retrospective Virology Analysis
Yoichiro Natori, University of Miami
Aasith Villavicencio Paz, University of Pennsylvania